Proceedings from the Albert Charitable Trust Inaugural Workshop on white matter and cognition in aging
暂无分享,去创建一个
M. Fornage | S. Carmichael | J. Graff‐Radford | E. Hamel | D. Wilcock | M. Duering | C. De Carli | M. Jensen | H. S. Markus | A. Montagne | F. Sorond | Andy Y. Shih | G. Rosenberg | E. Smith | K. Tse | D. Arnold | K. Arai | R. Flores-Obando | Alex Thiel | Shawn Whitehead | David C. Hess | Massafumi Ihara | Frank Barone | Rafael E. Flores-Obando | S. Whitehead | Ken Arai
[1] D. Norris,et al. Contribution of acute infarcts to cerebral small vessel disease progression , 2019, Annals of neurology.
[2] Andrew Gibson,et al. Impaired behavioural flexibility related to white matter microgliosis in the TgAPP21 rat model of Alzheimer disease , 2019, Brain, Behavior, and Immunity.
[3] K. Jin,et al. Systemic milieu and age-related deterioration , 2019, GeroScience.
[4] Philippe Pouliot,et al. Systolic hypertension-induced neurovascular unit disruption magnifies vascular cognitive impairment in middle-age atherosclerotic LDLr−/−:hApoB+/+ mice , 2019, GeroScience.
[5] Farzaneh A. Sorond,et al. Age-related decline in peripheral vascular health predicts cognitive impairment , 2019, GeroScience.
[6] T. Kiss,et al. Central IGF-1 protects against features of cognitive and sensorimotor decline with aging in male mice , 2019, GeroScience.
[7] Philippe Pouliot,et al. High Systolic Blood Pressure Induces Cerebral Microvascular Endothelial Dysfunction, Neurovascular Unit Damage, and Cognitive Decline in Mice , 2019, Hypertension.
[8] Stephen E. Jones,et al. Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study , 2018, The Lancet Neurology.
[9] V. Hachinski,et al. APP21 transgenic rats develop age-dependent cognitive impairment and microglia accumulation within white matter tracts , 2018, Journal of Neuroinflammation.
[10] Evan Z. Macosko,et al. Molecular Diversity and Specializations among the Cells of the Adult Mouse Brain , 2018, Cell.
[11] M. Ewers,et al. Free water determines diffusion alterations and clinical status in cerebral small vessel disease , 2018, Alzheimer's & Dementia.
[12] D. Norris,et al. Investigating the origin and evolution of cerebral small vessel disease: The RUN DMC – InTENse study , 2018, European stroke journal.
[13] Karl Herrup,et al. DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia , 2018, Alzheimer's & Dementia.
[14] C. Gu,et al. Regulation of Central Nervous System Myelination in Higher Brain Functions , 2018, Neural plasticity.
[15] Eric E. Smith,et al. Cerebral amyloid angiopathy as a cause of neurodegeneration , 2018, Journal of neurochemistry.
[16] D. Rosene,et al. Candidate molecular pathways of white matter vulnerability in the brain of normal aging rhesus monkeys , 2018, GeroScience.
[17] Peter J. Park,et al. Aging and neurodegeneration are associated with increased mutations in single human neurons , 2017, Science.
[18] K. Herrup,et al. Re‐imagining Alzheimer's disease – the diminishing importance of amyloid and a glimpse of what lies ahead , 2017, Journal of neurochemistry.
[19] H. Markus,et al. Change in multimodal MRI markers predicts dementia risk in cerebral small vessel disease , 2017, Neurology.
[20] V. Hachinski,et al. Behavioural inflexibility in a comorbid rat model of striatal ischemic injury and mutant hAPP overexpression , 2017, Behavioural Brain Research.
[21] M. Monje,et al. Wrapped to Adapt: Experience-Dependent Myelination , 2017, Neuron.
[22] T. Kiss,et al. Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer’s disease , 2017, GeroScience.
[23] Ernesto Fedele,et al. The Amyloid Cascade Hypothesis in Alzheimer’s Disease: It’s Time to Change Our Mind , 2017, Current neuropharmacology.
[24] Nadine C. Heyworth,et al. Microglia activation and phagocytosis: relationship with aging and cognitive impairment in the rhesus monkey , 2017, GeroScience.
[25] E. Audinat,et al. Microglia in CNS development: Shaping the brain for the future , 2017, Progress in Neurobiology.
[26] T. Kiss,et al. Cerebromicrovascular dysfunction predicts cognitive decline and gait abnormalities in a mouse model of whole brain irradiation-induced accelerated brain senescence , 2017, GeroScience.
[27] H. Vrenken,et al. White Matter Hyperintensity Volume and Cerebral Perfusion in Older Individuals with Hypertension Using Arterial Spin-Labeling , 2016, American Journal of Neuroradiology.
[28] S. Greenberg,et al. Progression of Brain Network Alterations in Cerebral Amyloid Angiopathy , 2016, Stroke.
[29] B. Boeve,et al. Multiple sclerosis masquerading as Alzheimer-type dementia: Clinical, radiological and pathological findings , 2016, Multiple sclerosis.
[30] S. Greenberg,et al. White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy , 2016, Neurology.
[31] E. Chang,et al. Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse , 2016, Neuron.
[32] H. Markus,et al. Progression of MRI markers in cerebral small vessel disease: Sample size considerations for clinical trials , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[33] Alan J. Thomas,et al. Frontal white matter hyperintensities, clasmatodendrosis and gliovascular abnormalities in ageing and post-stroke dementia , 2015, Brain : a journal of neurology.
[34] A. Araki,et al. Diabetes mellitus and white matter hyperintensity , 2015, Geriatrics & gerontology international.
[35] K. Kitamura,et al. Adrenomedullin Therapy in Patients with Refractory Ulcerative Colitis: A Case Series , 2015, Digestive Diseases and Sciences.
[36] K. Arai,et al. Adrenomedullin promotes differentiation of oligodendrocyte precursor cells into myelin-basic-protein expressing oligodendrocytes under pathological conditions in vitro. , 2015, Stem cell research.
[37] H. Iida,et al. A Novel Mouse Model of Subcortical Infarcts with Dementia , 2015, The Journal of Neuroscience.
[38] Lisa Cloonan,et al. Determinants of white matter hyperintensity burden differ at the extremes of ages of ischemic stroke onset. , 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[39] Jeffrey F. Thompson,et al. Hypoxia-Induced Neuroinflammatory White-Matter Injury Reduced by Minocycline in SHR/SP , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[40] O. Ciccarelli,et al. Exploring the origins of grey matter damage in multiple sclerosis , 2015, Nature Reviews Neuroscience.
[41] Joanna M. Wardlaw,et al. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden , 2014, Neurology.
[42] G. Dehaene-Lambertz,et al. The early development of brain white matter: A review of imaging studies in fetuses, newborns and infants , 2014, Neuroscience.
[43] T. Maniatis,et al. An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex , 2014, The Journal of Neuroscience.
[44] B. Zlokovic,et al. The Pericyte: A Forgotten Cell Type with Important Implications for Alzheimer's Disease? , 2014, Brain pathology.
[45] P. Durie,et al. Lessons from the Mouse Model , 2013 .
[46] Richard Frayne,et al. Neurovascular decoupling is associated with severity of cerebral amyloid angiopathy , 2013, Neurology.
[47] Douglas L. Rosene,et al. Age-related changes in human and non-human primate white matter: from myelination disturbances to cognitive decline , 2011, AGE.
[48] M. Ihara,et al. Lessons from a Mouse Model Characterizing Features of Vascular Cognitive Impairment with White Matter Changes , 2011, Journal of aging research.
[49] K. Nakao,et al. Angiogenic and Vasoprotective Effects of Adrenomedullin on Prevention of Cognitive Decline After Chronic Cerebral Hypoperfusion in Mice , 2011, Stroke.
[50] Terry L. Jernigan,et al. The Basics of Brain Development , 2010, Neuropsychology Review.
[51] Eric E. Smith,et al. MRI Markers of Small Vessel Disease in Lobar and Deep Hemispheric Intracerebral Hemorrhage , 2010, Stroke.
[52] H. Markus,et al. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.
[53] Karl Zilles,et al. Frontal White Matter Volume Is Associated with Brain Enlargement and Higher Structural Connectivity in Anthropoid Primates , 2010, PloS one.
[54] D. Mozaffarian,et al. Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond , 2010, Circulation.
[55] Sandra Black,et al. Understanding White Matter Disease: Imaging-Pathological Correlations in Vascular Cognitive Impairment , 2009, Stroke.
[56] A. Levey,et al. Development of transgenic rats producing human β-amyloid precursor protein as a model for Alzheimer's disease: Transgene and endogenous APP genes are regulated tissue-specifically , 2008, BMC Neuroscience.
[57] D. Harvey,et al. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD , 2006, Neurology.
[58] K. Nakao,et al. The neuroprotective and vasculo-neuro-regenerative roles of adrenomedullin in ischemic brain and its therapeutic potential. , 2006, Endocrinology.
[59] Yue Cao,et al. Use of magnetic resonance imaging to assess blood-brain/blood-glioma barrier opening during conformal radiotherapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[60] K. Herrup,et al. Loss of Neuronal Cell Cycle Control in Ataxia-Telangiectasia: A Unified Disease Mechanism , 2005, The Journal of Neuroscience.
[61] P. Schoenemann,et al. Prefrontal white matter volume is disproportionately larger in humans than in other primates , 2005, Nature Neuroscience.
[62] C. Masters,et al. Consensus neuropathological diagnosis of common dementia syndromes: testing and standardising the use of multiple diagnostic criteria , 2002, Acta Neuropathologica.
[63] H. Damasio,et al. Humans and great apes share a large frontal cortex , 2002, Nature Neuroscience.
[64] G. Bartzokis,et al. Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. , 2001, Archives of general psychiatry.
[65] A Hofman,et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study , 2001, Journal of neurology, neurosurgery, and psychiatry.
[66] J M Wardlaw,et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study: the Rotterdam Scan Study , 2001, Journal of neurology, neurosurgery, and psychiatry.
[67] G C Roman,et al. Brain infarction and the clinical expression of Alzheimer disease. , 1997, JAMA.
[68] W. Markesbery,et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.
[69] H. Braak,et al. Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis , 1996, Acta Neuropathologica.